Philippe Eigenmann

ORCID: 0000-0003-1738-1826
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Food Allergy and Anaphylaxis Research
  • Asthma and respiratory diseases
  • Allergic Rhinitis and Sensitization
  • Eosinophilic Esophagitis
  • Contact Dermatitis and Allergies
  • Respiratory and Cough-Related Research
  • Dermatology and Skin Diseases
  • Drug-Induced Adverse Reactions
  • Pediatric health and respiratory diseases
  • Child Nutrition and Feeding Issues
  • Infant Health and Development
  • Consumer Attitudes and Food Labeling
  • Immunodeficiency and Autoimmune Disorders
  • Urticaria and Related Conditions
  • Respiratory viral infections research
  • Inhalation and Respiratory Drug Delivery
  • Probiotics and Fermented Foods
  • Pharmaceutical studies and practices
  • IL-33, ST2, and ILC Pathways
  • Digestive system and related health
  • Immune Cell Function and Interaction
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Infant Nutrition and Health
  • Celiac Disease Research and Management
  • Autoimmune Bullous Skin Diseases

University Hospital of Geneva
2016-2025

Geneva College
2009-2025

University of Geneva
2015-2024

Hôpital des Enfants
2001-2024

Medical University of Warsaw
2024

SIB Swiss Institute of Bioinformatics
2009-2024

Chinese University of Hong Kong
2024

Hôpital Beau-Séjour
2016-2023

Agostino Gemelli University Polyclinic
2022

Hacettepe University
2022

Food allergy can result in considerable morbidity, impact negatively on quality of life, and prove costly terms medical care. These guidelines have been prepared by the European Academy Allergy Clinical Immunology's (EAACI) Guidelines for Anaphylaxis Group, building previous EAACI position papers adverse reaction to foods three recent systematic reviews epidemiology, diagnosis, management food allergy, provide evidence-based recommendations diagnosis allergy. While primary audience is...

10.1111/all.12429 article EN Allergy 2014-06-09

Anaphylaxis is a clinical emergency, and all healthcare professionals should be familiar with its recognition acute ongoing management. These guidelines have been prepared by the European Academy of Allergy Clinical Immunology (EAACI) Taskforce on Anaphylaxis. They aim to provide evidence-based recommendations for recognition, risk factor assessment, management patients who are at of, experiencing, or experienced anaphylaxis. While primary audience allergists, these also relevant other...

10.1111/all.12437 article EN Allergy 2014-06-09

The availability of allergen molecules ('components') from several protein families has advanced our understanding immunoglobulin E (IgE)-mediated responses and enabled 'component-resolved diagnosis' (CRD). European Academy Allergy Clinical Immunology (EAACI) Molecular Allergology User's Guide (MAUG) provides comprehensive information on important allergens describes the diagnostic options using CRD. Part A EAACI MAUG introduces molecules, families, composition extracts, databases, IgE,...

10.1111/pai.12563 article EN Pediatric Allergy and Immunology 2016-05-01

Objective. There is a growing body of clinical and laboratory evidence to support the notion that food allergy plays role in pathogenesis atopic dermatitis (AD). However, incidence IgE-mediated children with AD not well established. Design. A prospective study determine prevalence hypersensitivity among patients referred university-based dermatologist for evaluation AD. Setting. University hospital pediatric dermatology clinic. Patients. total 63 were recruited (35 male; 32 white, 24...

10.1542/peds.101.3.e8 article EN PEDIATRICS 1998-03-01

Anaphylaxis is a growing paediatric clinical emergency that difficult to diagnose because consensus definition was lacking until recently. Many European countries have no specific guidelines for anaphylaxis. This position paper prepared by the EAACI Taskforce on in Children aims provide practical managing anaphylaxis childhood based limited evidence available. Intramuscular adrenaline acknowledged first‐line therapy anaphylaxis, hospital and community, should be given as soon condition...

10.1111/j.1398-9995.2007.01421.x article EN Allergy 2007-06-21

Food allergy can result in considerable morbidity, impairment of quality life, and healthcare expenditure. There is therefore interest novel strategies for its treatment, particularly food allergen immunotherapy (FA-AIT) through the oral (OIT), sublingual (SLIT), or epicutaneous (EPIT) routes. This Guideline, prepared by European Academy Allergy Clinical Immunology (EAACI) Task Force on Allergen Immunotherapy IgE-mediated Allergy, aims to provide evidence-based recommendations active...

10.1111/all.13319 article EN Allergy 2017-09-28

Food allergy can have significant effects on morbidity and quality of life be costly in terms medical visits treatments. There is therefore considerable interest generating efficient approaches that may reduce the risk developing food allergy. This guideline has been prepared by European Academy Allergy Clinical Immunology's (EAACI) Taskforce Prevention part EAACI Guidelines for Anaphylaxis. It aims to provide evidence-based recommendations primary prevention A wide range antenatal,...

10.1111/all.12398 article EN Allergy 2014-04-03

This guideline from the European Academy of Allergy and Clinical Immunology (EAACI) recommends approaches to prevent development immediate-onset / IgE-mediated food allergy in infants young children. It is an update a 2014 EAACI guideline.The was developed using AGREE II framework GRADE approach. An international Task Force with representatives 11 countries different disciplinary clinical backgrounds systematically reviewed research considered expert opinion. Recommendations were created by...

10.1111/pai.13496 article EN Pediatric Allergy and Immunology 2021-03-12

This document provides supplementary guidance on specific topics for the allergenicity risk assessment of genetically modified plants. In particular, it supplements general recommendations outlined in previous EFSA GMO Panel guidelines and Implementing Regulation (EU) No 503/2013. The addressed are non-IgE-mediated adverse immune reactions to foods, vitro protein digestibility tests endogenous allergenicity. New scientific regulatory developments regarding these three described this...

10.2903/j.efsa.2017.4862 article EN cc-by-nd EFSA Journal 2017-06-01
Stephanie Dramburg Christiane Hilger Alexandra F. Santos Leticia de las Vecillas Rob C. Aalberse and 95 more Nathalie Acevedo Lorenz Aglas Friedrich Altmann L. Karla Arruda Riccardo Asero Barbara Ballmer‐Weber Domingo Barber Kirsten Beyer Tilo Biedermann Maria Beatrice Bilò Simon Blank Philipp P. Bosshard Heimo Breiteneder Helen A. Brough Merima Bublin Dianne E. Campbell Luis Caraballo Jean‐Christoph Caubet Giorgio Celi Martin D. Chapman M. Chruszcz Adnan Ćustović Rebecca Czolk Janet M. Davies Nikolaos Douladiris Bernadette Eberlein Motohiro Ebisawa Anna M. Ehlers Philippe Eigenmann Gabriele Gadermaier Mattia Giovannini Francisca Gómez Rebecca Grohman Carole Guillet Christine Häfner Robert G. Hamilton Michael Hauser Thomas Hawranek Hans Jürgen Hoffmann Thomas Holzhauser Tomona Iizuka Alain Jacquet Thilo Jakob Bente Janssen‐Weets Uta Jappe Marek Jutel Tanja Kalic Sandip D. Kamath S. Kespohl Jörg Kleine‐Tebbe Edward F. Knol André C. Knulst Jon R. Konradsen Peter Korošec Annette Kuehn Gideon Lack Thuy‐My Le Andreas L. Lopata Olga Luengo Mika J. Mäkelä Alessandro Maria Marra E. N. Clare Mills M. Morisset Antonella Muraro Anna Nowak‐Węgrzyn Roni Nugraha Markus Ollert Kati Palosuo Elide A. Pastorello Sarita U. Patil Thomas A.E. Platts‐Mills Anna Pomés Pascal Poncet Ekaterina Potapova Lars K. Poulsen Christian Radauer Suzana Radulovič Monika Raulf Pierre Rougé J. Sastre Sakura Sato Enrico Scala Johannes Martin Schmid Peter Schmid‐Grendelmeier Denise Schrama Hélène Sénéchal Claudia Traidl‐Hoffmann Marcela Valverde‐Monge Marianne van Hage Ronald van Ree Kitty Verhoeckx Stefan Vieths Magnus Wickman Josefina Zakzuk Paolo Maria Matricardi

Abstract Since the discovery of immunoglobulin E (IgE) as a mediator allergic diseases in 1967, our knowledge about immunological mechanisms IgE‐mediated allergies has remarkably increased. In addition to understanding immune response and clinical symptoms, allergy diagnosis management depend strongly on precise identification elicitors reaction. past four decades, innovations bioscience technology have facilitated production well‐defined, highly pure molecules for component‐resolved (CRD),...

10.1111/pai.13854 article EN cc-by-nc Pediatric Allergy and Immunology 2023-03-01

Abstract This European Academy of Allergy and Clinical Immunology guideline provides recommendations for diagnosing IgE‐mediated food allergy was developed using the Grading Recommendations, Assessment, Development Evaluations (GRADE) approach. Food diagnosis starts with an allergy‐focused clinical history followed by tests to determine IgE sensitization, such as serum allergen‐specific (sIgE) skin prick test (SPT), basophil activation (BAT), if available. Evidence sensitization should be...

10.1111/all.15902 article EN cc-by-nc Allergy 2023-10-10
Coming Soon ...